Praxis Precision Medicines (PRAX) Competitors $76.52 +3.68 (+5.05%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PRAX vs. BBIO, CRNX, KRYS, ACLX, ADMA, RARE, APLS, BHVN, IMVT, and RNAShould you be buying Praxis Precision Medicines stock or one of its competitors? The main competitors of Praxis Precision Medicines include BridgeBio Pharma (BBIO), Crinetics Pharmaceuticals (CRNX), Krystal Biotech (KRYS), Arcellx (ACLX), ADMA Biologics (ADMA), Ultragenyx Pharmaceutical (RARE), Apellis Pharmaceuticals (APLS), Biohaven (BHVN), Immunovant (IMVT), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry. Praxis Precision Medicines vs. BridgeBio Pharma Crinetics Pharmaceuticals Krystal Biotech Arcellx ADMA Biologics Ultragenyx Pharmaceutical Apellis Pharmaceuticals Biohaven Immunovant Avidity Biosciences BridgeBio Pharma (NASDAQ:BBIO) and Praxis Precision Medicines (NASDAQ:PRAX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk, community ranking and media sentiment. Which has better valuation and earnings, BBIO or PRAX? Praxis Precision Medicines has lower revenue, but higher earnings than BridgeBio Pharma. BridgeBio Pharma is trading at a lower price-to-earnings ratio than Praxis Precision Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBridgeBio Pharma$217.77M22.99-$643.20M-$2.41-10.99Praxis Precision Medicines$1.61M888.59-$123.28M-$10.30-7.43 Do analysts prefer BBIO or PRAX? BridgeBio Pharma presently has a consensus price target of $47.69, indicating a potential upside of 80.04%. Praxis Precision Medicines has a consensus price target of $146.33, indicating a potential upside of 91.24%. Given Praxis Precision Medicines' stronger consensus rating and higher possible upside, analysts plainly believe Praxis Precision Medicines is more favorable than BridgeBio Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BridgeBio Pharma 0 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.86Praxis Precision Medicines 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Is BBIO or PRAX more profitable? BridgeBio Pharma has a net margin of -201.53% compared to Praxis Precision Medicines' net margin of -9,409.22%. BridgeBio Pharma's return on equity of 0.00% beat Praxis Precision Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BridgeBio Pharma-201.53% N/A -74.34% Praxis Precision Medicines -9,409.22%-54.86%-50.52% Does the MarketBeat Community believe in BBIO or PRAX? BridgeBio Pharma received 125 more outperform votes than Praxis Precision Medicines when rated by MarketBeat users. However, 72.41% of users gave Praxis Precision Medicines an outperform vote while only 71.06% of users gave BridgeBio Pharma an outperform vote. CompanyUnderperformOutperformBridgeBio PharmaOutperform Votes16771.06% Underperform Votes6828.94% Praxis Precision MedicinesOutperform Votes4272.41% Underperform Votes1627.59% Do institutionals and insiders believe in BBIO or PRAX? 99.8% of BridgeBio Pharma shares are owned by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are owned by institutional investors. 24.7% of BridgeBio Pharma shares are owned by company insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor BBIO or PRAX? In the previous week, BridgeBio Pharma had 1 more articles in the media than Praxis Precision Medicines. MarketBeat recorded 10 mentions for BridgeBio Pharma and 9 mentions for Praxis Precision Medicines. Praxis Precision Medicines' average media sentiment score of 1.07 beat BridgeBio Pharma's score of 0.86 indicating that Praxis Precision Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BridgeBio Pharma 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Praxis Precision Medicines 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, BBIO or PRAX? BridgeBio Pharma has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.67, suggesting that its share price is 167% more volatile than the S&P 500. SummaryBridgeBio Pharma and Praxis Precision Medicines tied by winning 9 of the 18 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRAX vs. The Competition Export to ExcelMetricPraxis Precision MedicinesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.43B$6.57B$5.02B$9.08BDividend YieldN/A3.09%4.87%4.20%P/E Ratio-7.4310.55135.0817.16Price / Sales888.59194.011,120.30115.67Price / CashN/A57.1640.5837.88Price / Book9.665.104.754.78Net Income-$123.28M$151.51M$118.50M$225.60M7 Day Performance9.03%-2.13%-1.85%-1.21%1 Month Performance4.31%-3.13%11.28%3.09%1 Year Performance285.30%11.54%29.91%16.48% Praxis Precision Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRAXPraxis Precision Medicines2.4059 of 5 stars$76.52+5.1%$146.33+91.2%+323.0%$1.43B$1.61M-7.43110Gap DownBBIOBridgeBio Pharma4.6959 of 5 stars$27.75+0.9%$47.69+71.9%-30.7%$5.24B$217.77M-11.63400CRNXCrinetics Pharmaceuticals4.0687 of 5 stars$54.32+1.2%$70.82+30.4%+55.4%$5.04B$1.04M-14.39210Positive NewsKRYSKrystal Biotech4.5152 of 5 stars$171.41+4.7%$206.67+20.6%+45.9%$4.93B$50.70M92.45229Analyst ForecastACLXArcellx3.1314 of 5 stars$84.46+0.8%$105.93+25.4%+49.1%$4.57B$155.82M-118.03130Positive NewsADMAADMA Biologics3.776 of 5 stars$19.02+2.3%$21.25+11.7%+325.4%$4.50B$382.81M68.32530Positive NewsGap DownRAREUltragenyx Pharmaceutical4.4437 of 5 stars$46.04+0.6%$87.46+90.0%-2.6%$4.25B$434.25M-7.081,276Analyst ForecastNews CoveragePositive NewsAPLSApellis Pharmaceuticals4.563 of 5 stars$33.99+2.4%$49.94+46.9%-39.6%$4.23B$396.59M-16.35702Analyst DowngradeBHVNBiohaven3.7123 of 5 stars$41.46+7.8%$63.00+52.0%-4.4%$4.19B$462.51M-4.11239Analyst ForecastIMVTImmunovant1.4541 of 5 stars$27.38+4.2%$47.89+74.9%-28.5%$4.02BN/A-11.84120Analyst ForecastNews CoverageRNAAvidity Biosciences2.1843 of 5 stars$33.66+3.6%$63.60+88.9%+278.8%$4.02B$10.12M-11.28190Analyst ForecastInsider TradeAnalyst RevisionNews Coverage Related Companies and Tools Related Companies BridgeBio Pharma Competitors Crinetics Pharmaceuticals Competitors Krystal Biotech Competitors Arcellx Competitors ADMA Biologics Competitors Ultragenyx Pharmaceutical Competitors Apellis Pharmaceuticals Competitors Biohaven Competitors Immunovant Competitors Avidity Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRAX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRAX Stock Alerts